Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Curaleaf jockeying to capitalize on a European position

<< Previous

Bullboard Posts

Next >>

Comment by subaru1ion Mar 19, 2024 10:25am

45 Views

Post# 35940448

RE:Curaleaf jockeying to capitalize on a European position

It tells me something different, the move by Curaleaf....that LABS is 'hands off', we have a legal partner already otherwise LABS would have been a much better purchase by Curaleaf. That LABS FDA site approval for pharmacueticals is worth a lot of money.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023